Coronavirus disease (COVID-19) comes from a strain of coronavirus, or SARS-CoV-2, first detected in December 2019. In response to the evolving health emergency, HTA Philippines has been conducting rapid reviews to support policy- and decision-makers. Recognizing calls to strengthen national crisis response efforts, we conduct our assessments at the request of the Secretary of Health. continue reading : COVID-19 Guidance
COVID -19 Devices
HIGH-FLOW NASAL CANNULA OXYGEN THERAPY FOR THE TREATMENT OF ACUTE HYPOXEMIC RESPIRATORY FAILURE FOR COVID-19 JANUARY 24, 2021 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR COVID-19 PATIENTS WITH ARDS SEPTEMBER 25, 2020 HUAWEI CLOUD AI-ASSISTED DIAGNOSIS JULY 30, 2020 AMTI UAI-DISCOVER-PNA JULY 30, 2020
HTAC Evaluating CoronaVac (Sinovac), Awaits More Data
Contrary to earlier news reports, the Health Technology Assessment Council (HTAC) has not yet issued any recommendation with regard to the use of CoronaVac vaccine from Sinovac. HTAC is currently in the process of evaluating evidence on the said COVID-19 vaccine, and is awaiting more data. Recognizing the importance of the potential of all COVID-19 continue reading : HTAC Evaluating CoronaVac (Sinovac), Awaits More Data